Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Yoon

Showing results (911-920 of 954) with videos related to

Pageof 96
Sort By:
Biorxiv : the Preprint Server for Biology|October 17, 2024
ADT-1004: A First-in-Class, Orally Bioavailable Selective pan-RAS Inhibitor for Pancreatic Ductal AdenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Biomarker Research|June 6, 2021
The REASON score: an epigenetic and clinicopathologic score to predict risk of poor survival in patients with early stage oral squamous cell carcinomaChi T Viet, Gary Yu, Kesava Asam, et al.
Molecular Cancer|March 14, 2025
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Blood Advances|May 13, 2024
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current eraAnand A Patel, James J Yoon, Hannah Johnston, et al.
Nature|July 21, 2010
Epigenetic memory in induced pluripotent stem cellsK Kim, A Doi, B Wen, et al.
Current Protocols in Stem Cell Biology|April 16, 2020
Generation and Characterization of Patient-Derived Head and Neck, Oral, and Esophageal Cancer OrganoidsTatiana A Karakasheva, Takashi Kijima, Masataka Shimonosono, et al.
US CLIVAR Reports|October 22, 2019
ARCTIC CHANGE AND POSSIBLE INFLUENCE ON MID-LATITUDE CLIMATE AND WEATHER: A US CLIVAR White PaperJ Cohen, X Zhang, J Francis, et al.
Physical Review Letters|October 15, 2013
Measurement of the neutron electric to magnetic form factor ratio at Q2=1.58  GeV2 using the reaction 3He[over →](e[over →],e'n)ppB S Schlimme, P Achenbach, C A Ayerbe Gayoso, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 29, 2021
The role of CDHR3 in susceptibility to otitis mediaScott D Hirsch, Christina L Elling, Tori C Bootpetch, et al.
Nature Communications|May 8, 2021
Co-evolution of tumor and immune cells during progression of multiple myelomaRuiyang Liu, Qingsong Gao, Steven M Foltz, et al.
Pageof 96

Showing results (911-920 of 954) with videos related to

Sort By:
Pageof 96
Biorxiv : the Preprint Server for Biology|October 17, 2024
ADT-1004: A First-in-Class, Orally Bioavailable Selective pan-RAS Inhibitor for Pancreatic Ductal AdenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Biomarker Research|June 6, 2021
The REASON score: an epigenetic and clinicopathologic score to predict risk of poor survival in patients with early stage oral squamous cell carcinomaChi T Viet, Gary Yu, Kesava Asam, et al.
Molecular Cancer|March 14, 2025
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinomaDhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Blood Advances|May 13, 2024
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current eraAnand A Patel, James J Yoon, Hannah Johnston, et al.
Nature|July 21, 2010
Epigenetic memory in induced pluripotent stem cellsK Kim, A Doi, B Wen, et al.
Current Protocols in Stem Cell Biology|April 16, 2020
Generation and Characterization of Patient-Derived Head and Neck, Oral, and Esophageal Cancer OrganoidsTatiana A Karakasheva, Takashi Kijima, Masataka Shimonosono, et al.
US CLIVAR Reports|October 22, 2019
ARCTIC CHANGE AND POSSIBLE INFLUENCE ON MID-LATITUDE CLIMATE AND WEATHER: A US CLIVAR White PaperJ Cohen, X Zhang, J Francis, et al.
Physical Review Letters|October 15, 2013
Measurement of the neutron electric to magnetic form factor ratio at Q2=1.58  GeV2 using the reaction 3He[over →](e[over →],e'n)ppB S Schlimme, P Achenbach, C A Ayerbe Gayoso, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 29, 2021
The role of CDHR3 in susceptibility to otitis mediaScott D Hirsch, Christina L Elling, Tori C Bootpetch, et al.
Nature Communications|May 8, 2021
Co-evolution of tumor and immune cells during progression of multiple myelomaRuiyang Liu, Qingsong Gao, Steven M Foltz, et al.
Pageof 96